Xeomin

Xeomin, produced by Merz Aesthetics, is botulinum toxin A that acts as a therapeutic muscle-relaxing agent. Xeomin received FDA approval in the United States in 2011 for the temporary improvement of moderate to severe frown lines between the eyebrows in adults under 65 years of age.